← Browse by Condition
Medical Condition

cervical radiculopathy

Total Trials
5
Recruiting Now
5
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for cervical radiculopathy sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cervical radiculopathy Clinical Trials

How many clinical trials are currently recruiting for cervical radiculopathy?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for cervical radiculopathy, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cervical radiculopathy?
cervical radiculopathy research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cervical radiculopathy clinical trial?
Eligibility criteria for cervical radiculopathy trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Shin Kong Wu Ho-Su Memorial Hospital 1 trial
Marmara University 1 trial
Necmettin Erbakan University 1 trial
Cairo University 1 trial
Ibadat International University, Islamabad 1 trial

Recruiting Clinical Trials

NCT07207356
Recruiting
Ultrasound Guided Transcutaneous Pulsed Radiofrequency for Cervical Radiculopathy
Enrollment
32 pts
Location
Taiwan
Sponsor
Shin Kong Wu Ho-Su Memorial Ho...
View Trial →
NCT07307846
Recruiting
Investigation of the Effects of Interlaminar Epidural Steroid Injection on Upper Extremity Proprioception in Patients With Chronic Cervical Radiculopathy
Enrollment
46 pts
Location
Turkey (Türkiye)
Sponsor
Marmara University
View Trial →
NCT07506785
Recruiting
Home-Based Exercise After Cervical Epidural Steroid Injection for Cervical Radiculopathy
Enrollment
60 pts
Location
Turkey (Türkiye)
Sponsor
Necmettin Erbakan University
View Trial →
NCT06102304
Recruiting
Myo-Electrical and Nerve Root Function Response to Focused Extracorpeal Shock Wave in Cervical Radiculopathy
Enrollment
80 pts
Location
Egypt
Sponsor
Cairo University
View Trial →
NCT07808476
Recruiting
Efficacy Of Gross Myofascial Release With Neural Mobilization Versus Neural Mobilization Alone On Pain, Functional Limitations, And Cervical Range Of Motion In Cervical Radiculopathy
Enrollment
44 pts
Location
Pakistan
Sponsor
Ibadat International Universit...
View Trial →

Related Conditions

cervical radicular pain (1) proprioception (1) home based rehabilitation (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology